— Know what they know.
Not Investment Advice

BNR Short Interest

Burning Rock Biotech Limited
1W: -2.0% 1M: -29.6% 3M: +40.7% YTD: -36.9% 1Y: -5.0% 3Y: +21.7% 5Y: -91.5%
$11.87
+0.72 (+6.46%)
 
Weekly Expected Move ±14.0%
$9 $10 $12 $13 $15
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Sell · Power 35 · $12.5M mcap · 876463 float · 3.25% daily turnover · Short 25% of daily vol
Credit Risk of going bust: higher than 94% of companies Debt: 35.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $1.35 (down 89%), Burning Rock Biotech Limited would be worth roughly what it owes.
Total debt $6.8M against a stock market value of $12.5M.
Distance to default 1.00 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.3M (short-term plus half of long-term), stock volatility 126.3%; Altman Z'' -13.32. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
24.6%
Short Ratio
of total volume
37.5%
20-Day Avg
40.5%
50-Day Avg
▼ Falling
5-Day Trend
0.0M
Short Volume
0.0M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 3,149 13,232 23.8%
NYSE 200 403 49.6%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms